Rheumatology Doctors in Roanoke, VA Accepting Medicare

5 Rheumatology doctors found. Showing 1 - 5

Dr. Adegbenga A. Bankole, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3 Rivers Circle, Suite 302, Roanoke, VA 24016 Phone: 540-224-5170    Fax: 540-983-8229

Dr. Jane N Nwaonu, MD Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3 Riverside Cir, Roanoke, VA 24016 Phone: 540-224-5170    Fax: 540-526-1099

John W. Pendleton, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 3 Rivers Circle, Roanoke, VA 24016 Phone: 540-224-5170    Fax: 540-983-8229

Robert Riley Johnson, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 3 Riverside Circle, 302, Roanoke, VA 24016 Phone: 540-224-5170    Fax: 540-983-8229

Dr. Timothy James Henshaw, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 6335 Corntassel Ln, Roanoke, VA 24018 Phone: 540-776-1553

News Archive

Bachmann's parting shot: Repeal health law

News outlets noted that as she announced she was leaving the GOP presidential race, Rep. Michele Bachmann continued to criticize the Affordable Care Act

Prostate cancer patients treated with CyberKnife Robotic Radiosurgery System enrolled in RPCR

The CyberKnife Coalition announced today that more than 500 men treated with the CyberKnife Robotic Radiosurgery System have now been enrolled in the first national patient registry designed specifically to track prostate cancer patients treated with stereotactic body radiation therapy.

Ground-breaking discovery could lead to new treatments for diabetes

Why would a bacteria-killing protein be present in an area of the body that is not normally exposed to bacteria, like the pancreas? Researchers at The Ottawa Hospital and the University of Ottawa puzzled over this question for some time, until they eventually discovered that the protein in question was doing something entirely unexpected - it was actually helping the pancreas regenerate and produce insulin.

InterMune to launch Esbriet for German patients with IPF

InterMune, Inc. today announced that Esbriet will be offered to patients in Germany beginning September 15, 2011. This will mark the first time Esbriet will be commercially available in Europe since it was approved by the European Commission in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF), a devastating and fatal lung disease.

Read more Medical News

› Verified 9 days ago